Optometric Profession Updates

Your source for news and updates of significance for the optometric profession.  

Zoster Eye Disease Study (ZEDS) - March 2021

The Zoster Eye Disease Study (ZEDS), a NEI/NIH supported double-masked placebo-controlled clinical trial to determine whether 1 year of suppressive valacyclovir treatment reduces complications of Herpes Zoster Ophthalmicus, including eye disease and/or postherpetic neuralgia.  At a recent DSMC meeting it was recommended that we work with optometrists to increase enrollment.  A list of current active Participating Clinical Centers (PCC) can be found below. There are approximately 80 centers, including 70 across the United States, 9 in Canada and 1 in New Zealand. We are not adding new centers. We hope very much that optometrists will refer their HZO patients who are immunocompetent, have a history of a typical HZO rash anytime in the past, and a record of an episode of active keratitis or iritis within the past year to our centers for possible enrollment.

This is a wonderful opportunity for our professions to work together to promote science and public health by developing a high-quality evidence-based new standard of care to improve outcomes in HZO. I am happy to provide you with additional information and answer any questions.


Elisabeth J. Cohen, MD
Professor of Ophthalmology,
NYU Grossman School of Medicine, NYU Langone Health

View Active PCC List



President's Calling - Safety First

Published September 1, 2021